Skip to content
★ Sign in to follow
IP

Innovation Pharmaceuticals Inc. Stock: price and insider trades · United States

US·Mcap US$155.5k

Innovation Pharmaceuticals Inc.: what insiders have been doing

Innovation Pharmaceuticals Inc. has a thin disclosure history in our data (latest filing: 28 September 2022). New filings will appear here as soon as they are published. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Insider Decl.
21
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

as of FY 2023

FY ended June 2023 · cache

US$0.00
Analyst consensus
·
Income statement
EBITDA-US$2.7M
Net income-US$3.2M0.0% margin
Valuation
P/Book0.2x
Beta140.11
Balance sheet & cash
Market capUS$155.5k
Total debtUS$268k
Free Cash Flow-US$2.2M
Debt / Equity60%
Profitability & ownership
ROE-114.3%
ROA-18.4%
% insiders0.0%
% institutions0.0%
Last declaration on 28 September 2022
Declarations21 total
  • ◆
    Vice PresidentExecutives
    0SEC
    1,000 shares0Class A Common StockSEC:0001477932-22-007274:0
  • ◆
    Vice PresidentExecutives
    0SEC
    58,394 shares0Class A Common StockSEC:0001477932-22-007274:1
  • ◆
    Vice PresidentExecutives
    0SEC
    21,606 shares0Class A Common StockSEC:0001477932-22-007274:2
  • ◆
    Vice PresidentExecutives
    0SEC
    58,394 shares0Class A Common StockSEC:0001477932-22-007274:3
  • ◆
    DirectorExecutives
    0SEC
    500,000 shares0Class A Common StockSEC:0001477932-22-007268:0
  • ◆
    DirectorExecutives
    0SEC
    500,000 shares0Class A Common StockSEC:0001477932-22-007270:0
  • ◆
    Vice PresidentExecutives
    1,250 USD14SEC
    9,619 shares@ US$0.1326.2% of flowClass A Common StockSEC:0001123292-19-001107:0
  • ◆
    President and CMOExecutives
    54,809 USD15SEC
    421,611 shares@ US$0.1339.8% of flowClass A Common StockSEC:0001123292-19-001106:0
  • ◆
    Vice PresidentExecutives
    3,709 USD18SEC
    9,272 shares@ US$0.4073.8% of flowClass A Common StockSEC:0001123292-18-001007:0
  • ◆
    President and CMOExecutives
    87,578 USD17SEC
    218,946 shares@ US$0.4060.2% of flowClass A Common StockSEC:0001123292-18-001005:0
  • ◆
    Vice PresidentExecutives
    0SEC
    58,394 shares0Class A Common StockSEC:0001123292-18-000970:0
  • ◆
    President and CMOExecutives
    0SEC
    1,066,667 shares0Class A Common StockSEC:0001123292-18-000972:0
  • ◆
    Vice PresidentExecutives
    4,300 USD16SEC
    6,056 shares@ US$0.7145.4% of flowClass A Common StockSEC:0001123292-17-001399:1
  • ◆
    Vice PresidentExecutives
    0SEC
    58,394 shares0Class A Common StockSEC:0001123292-17-001399:0
  • ◆
    Pres. & Chief Medical OfficerExecutives
    0SEC
    1,066,667 shares0Class A Common StockSEC:0001123292-17-001401:0
  • ◆
    Pres. & Chief Medical OfficerExecutives
    0SEC
    1,066,667 shares0Common StockSEC:0001477932-16-011219:0
  • ●
    President and CSOExecutives
    0SEC
    6,000,000 shares0Common StockSEC:0001477932-15-007696:0
  • ●
    Chief Executive OfficerExecutives
    0SEC
    50,000 shares0Class A Common par value $0.0001SEC:0001477932-15-000002:0
  • ●
    President, CSOExecutives
    0SEC
    10,000,000 shares0Common StockSEC:0001477932-14-004875:0
  • ●
    Chief Executive OfficerExecutives
    0SEC
    110,000 shares0Class A Common par value #0.0001SEC:0001288099-13-000001:0
  • ●
    Chief Executive OfficerExecutives
    0SEC
    1,000,000 shares0CommonSEC:0001288099-12-000001:0

21 of 21 declarations

About Innovation Pharmaceuticals Inc.

Innovation Pharmaceuticals Inc. is a biopharmaceutical company focused on developing innovative treatments for serious diseases. The company is listed on NASDAQ under the symbol IPIX.